Zobrazeno 1 - 4
of 4
pro vyhledávání: '"BANAFSHEH ZAHEDI"'
Autor:
Emelie Curovic Rotbain, Henrik Frederiksen, Henrik Hjalgrim, Klaus Rostgaard, Gudrun Jakubsdottir Egholm, Banafsheh Zahedi, Christian Bjørn Poulsen, Lisbeth Enggard, Caspar da Cunha-Bang, Carsten Utoft Niemann
Publikováno v:
Haematologica, Vol 105, Iss 6 (2020)
Patients with chronic lymphocytic leukemia and unmutated immunoglobulin heavy-chain variable region gene (IGHV) have inferior survival from time of treatment in clinical studies. We assessed real-world outcomes based on mutational status and treatmen
Externí odkaz:
https://doaj.org/article/1e930cc1384d4daa97e8514fe68c0524
Autor:
VANITA R. ARODA, MORTEN T. ABILDLUND, RIKKE AGESEN, STEWART B. HARRIS, BANAFSHEH ZAHEDI, BERNARD ZINMAN, EIICHI ARAKI
Publikováno v:
Diabetes. 71
The PIONEER 8 (NCT03021187) trial demonstrated significant glucose-lowering efficacy of oral semaglutide vs. placebo (pbo) in patients (pts) with T2D inadequately controlled with insulin. Additionally, those assigned to oral semaglutide (7 or 14 mg d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d831aeebe703a4da0f1425535544dc8
https://doi.org/10.2337/db22-721-p
https://doi.org/10.2337/db22-721-p
Autor:
Vanita Aroda, Morten Tind Abildlund, Rikke Mette Agesen, Stewart Harris, Banafsheh Zahedi, Bernard Zinman, Eiichi Araki
Publikováno v:
Canadian Journal of Diabetes. 46:S5-S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd55ecb1c4e01a871c24cd6b1b821c48
https://doi.org/10.1016/j.jcjd.2022.09.014
https://doi.org/10.1016/j.jcjd.2022.09.014
Autor:
Caspar da Cunha-Bang, Klaus Rostgaard, Carsten Utoft Niemann, Gudrun Jakubsdottir Egholm, Emelie Curovic Rotbain, Christian Bjørn Poulsen, Banafsheh Zahedi, Lisbeth Enggard, Henrik Hjalgrim, Henrik Frederiksen
Publikováno v:
Haematologica
Rotbain, E C, Frederiksen, H, Hjalgrim, H, Rostgaard, K, Egholm, G J, Zahedi, B, Poulsen, C B, Enggard, L, Da Cunha-Bang, C & Niemann, C U 2020, ' IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment : A danish nationwide population-based study ', Haematologica, vol. 105, no. 6, pp. 1621-1629 . https://doi.org/10.3324/haematol.2019.220194
Rotbain, E C, Frederiksen, H, Hjalgrim, H, Rostgaard, K, Egholm, G J, Zahedi, B, Poulsen, C B, Enggard, L, da Cunha-Bang, C & Niemann, C U 2020, ' IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment : a Danish nationwide population-based study ', Haematologica, vol. 105, no. 6, pp. 1621-1629 . https://doi.org/10.3324/haematol.2019.220194
Rotbain, E C, Frederiksen, H, Hjalgrim, H, Rostgaard, K, Egholm, G J, Zahedi, B, Poulsen, C B, Enggard, L, Da Cunha-Bang, C & Niemann, C U 2020, ' IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment : A danish nationwide population-based study ', Haematologica, vol. 105, no. 6, pp. 1621-1629 . https://doi.org/10.3324/haematol.2019.220194
Rotbain, E C, Frederiksen, H, Hjalgrim, H, Rostgaard, K, Egholm, G J, Zahedi, B, Poulsen, C B, Enggard, L, da Cunha-Bang, C & Niemann, C U 2020, ' IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment : a Danish nationwide population-based study ', Haematologica, vol. 105, no. 6, pp. 1621-1629 . https://doi.org/10.3324/haematol.2019.220194
Patients with chronic lymphocytic leukemia and unmutated immunoglobulin heavy-chain variable region gene (IGHV) have inferior survival from time of treatment in clinical studies. We assessed real-world outcomes based on mutational status and treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3363cecd5df40ad4f0e65346cce8f0e2
https://pubmed.ncbi.nlm.nih.gov/31582540
https://pubmed.ncbi.nlm.nih.gov/31582540